135 related articles for article (PubMed ID: 20041138)
1. Differential effects of thiazolidinediones on adipocyte growth and recruitment in Zucker fatty rats.
MacKellar J; Cushman SW; Periwal V
PLoS One; 2009 Dec; 4(12):e8196. PubMed ID: 20041138
[TBL] [Abstract][Full Text] [Related]
2. Mechanism by which a novel non-thiazolidinedione peroxisome proliferator-activated receptor gamma agonist, FK614, ameliorates insulin resistance in Zucker fatty rats.
Minoura H; Takeshita S; Kimura C; Hirosumi J; Takakura S; Kawamura I; Seki J; Manda T; Mutoh S
Diabetes Obes Metab; 2007 May; 9(3):369-78. PubMed ID: 17391165
[TBL] [Abstract][Full Text] [Related]
3. Insulin-sensitizing effect of rosiglitazone (BRL-49653) by regulation of glucose transporters in muscle and fat of Zucker rats.
Kramer D; Shapiro R; Adler A; Bush E; Rondinone CM
Metabolism; 2001 Nov; 50(11):1294-300. PubMed ID: 11699047
[TBL] [Abstract][Full Text] [Related]
4. Pioglitazone-induced increase of insulin sensitivity in the muscles of the obese Zucker fa/fa rat cannot be explained by local adipocyte differentiation.
Hallakou S; Foufelle F; Doaré L; Kergoat M; Ferré P
Diabetologia; 1998 Aug; 41(8):963-8. PubMed ID: 9726600
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of peroxisome proliferator activator receptor-alpha and gamma ligands on intimal hyperplasia after balloon catheter-induced vascular injury in Zucker rats.
Desouza CV; Murthy SN; Diez J; Dunne B; Matta AS; Fonseca VA; McNamara DB
J Cardiovasc Pharmacol Ther; 2003 Dec; 8(4):297-305. PubMed ID: 14740079
[TBL] [Abstract][Full Text] [Related]
6. PPARγ activation alters fatty acid composition in adipose triglyceride, in addition to proliferation of small adipocytes, in insulin resistant high-fat fed rats.
Sato D; Oda K; Kusunoki M; Nishina A; Takahashi K; Feng Z; Tsutsumi K; Nakamura T
Eur J Pharmacol; 2016 Feb; 773():71-7. PubMed ID: 26825545
[TBL] [Abstract][Full Text] [Related]
7. Rosiglitazone, an agonist of peroxisome-proliferator-activated receptor gamma (PPARgamma), decreases inhibitory serine phosphorylation of IRS1 in vitro and in vivo.
Jiang G; Dallas-Yang Q; Biswas S; Li Z; Zhang BB
Biochem J; 2004 Jan; 377(Pt 2):339-46. PubMed ID: 14556646
[TBL] [Abstract][Full Text] [Related]
8. Pyruvate dehydrogenase kinase 4: regulation by thiazolidinediones and implication in glyceroneogenesis in adipose tissue.
Cadoudal T; Distel E; Durant S; Fouque F; Blouin JM; Collinet M; Bortoli S; Forest C; Benelli C
Diabetes; 2008 Sep; 57(9):2272-9. PubMed ID: 18519799
[TBL] [Abstract][Full Text] [Related]
9. INT131: a selective modulator of PPAR gamma.
Motani A; Wang Z; Weiszmann J; McGee LR; Lee G; Liu Q; Staunton J; Fang Z; Fuentes H; Lindstrom M; Liu J; Biermann DH; Jaen J; Walker NP; Learned RM; Chen JL; Li Y
J Mol Biol; 2009 Mar; 386(5):1301-11. PubMed ID: 19452630
[TBL] [Abstract][Full Text] [Related]
10. Prolonged decrease of adipocyte size after rosiglitazone treatment in high- and low-fat-fed rats.
Johnson JA; Trasino SE; Ferrante AW; Vasselli JR
Obesity (Silver Spring); 2007 Nov; 15(11):2653-63. PubMed ID: 18070756
[TBL] [Abstract][Full Text] [Related]
11. Ameliorating effect of FK614, a novel nonthiazolidinedione peroxisome proliferator-activated receptor gamma agonist, on insulin resistance in Zucker fatty rat.
Minoura H; Takeshita S; Yamamoto T; Mabuchi M; Hirosumi J; Takakura S; Kawamura I; Seki J; Manda T; Ita M; Mutoh S
Eur J Pharmacol; 2005 Sep; 519(1-2):182-90. PubMed ID: 16039648
[TBL] [Abstract][Full Text] [Related]
12. Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance.
de Souza CJ; Eckhardt M; Gagen K; Dong M; Chen W; Laurent D; Burkey BF
Diabetes; 2001 Aug; 50(8):1863-71. PubMed ID: 11473050
[TBL] [Abstract][Full Text] [Related]
13. Depot-specific regulation of perilipin by rosiglitazone in a diabetic animal model.
Kim HJ; Jung TW; Kang ES; Kim DJ; Ahn CW; Lee KW; Lee HC; Cha BS
Metabolism; 2007 May; 56(5):676-85. PubMed ID: 17445544
[TBL] [Abstract][Full Text] [Related]
14. Rosiglitazone treatment enhances intracellular actin dynamics and glucose transport in hypertrophic adipocytes.
Fryklund C; Morén B; Neuhaus M; Periwal V; Stenkula KG
Life Sci; 2022 Jun; 299():120537. PubMed ID: 35398016
[TBL] [Abstract][Full Text] [Related]
15. Pioglitazone induces in vivo adipocyte differentiation in the obese Zucker fa/fa rat.
Hallakou S; Doaré L; Foufelle F; Kergoat M; Guerre-Millo M; Berthault MF; Dugail I; Morin J; Auwerx J; Ferré P
Diabetes; 1997 Sep; 46(9):1393-9. PubMed ID: 9287037
[TBL] [Abstract][Full Text] [Related]
16. Divergent effects of rosiglitazone on protein-mediated fatty acid uptake in adipose and in muscle tissues of Zucker rats.
Coort SL; Coumans WA; Bonen A; van der Vusse GJ; Glatz JF; Luiken JJ
J Lipid Res; 2005 Jun; 46(6):1295-302. PubMed ID: 15772429
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of insulin signaling in tissues of Zucker obese rats after acute and long-term treatment with PPARgamma agonists.
Jiang G; Dallas-Yang Q; Li Z; Szalkowski D; Liu F; Shen X; Wu M; Zhou G; Doebber T; Berger J; Moller DE; Zhang BB
Diabetes; 2002 Aug; 51(8):2412-9. PubMed ID: 12145152
[TBL] [Abstract][Full Text] [Related]
18. Waves of adipose tissue growth in the genetically obese Zucker fatty rat.
MacKellar J; Cushman SW; Periwal V
PLoS One; 2010 Jan; 5(1):e8197. PubMed ID: 20107501
[TBL] [Abstract][Full Text] [Related]
19. Pioglitazone enhances small-sized adipocyte proliferation in subcutaneous adipose tissue.
Kajita K; Mori I; Hanamoto T; Ikeda T; Fujioka K; Yamauchi M; Okada H; Usui T; Takahashi N; Kitada Y; Taguchi K; Kajita T; Uno Y; Morita H; Ishizuka T
Endocr J; 2012; 59(12):1107-14. PubMed ID: 22972172
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, protects against nephropathy and pancreatic islet abnormalities in Zucker fatty rats.
Buckingham RE; Al-Barazanji KA; Toseland CD; Slaughter M; Connor SC; West A; Bond B; Turner NC; Clapham JC
Diabetes; 1998 Aug; 47(8):1326-34. PubMed ID: 9703335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]